Microbot Medical Inc. (MBOT) DCF Valuation

Valoración de DCF de Microbot Medical Inc. (MBOT)

US | Healthcare | Medical - Instruments & Supplies | NASDAQ
Microbot Medical Inc. (MBOT) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Microbot Medical Inc. (MBOT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Explore las perspectivas financieras de Microbot Medical Inc. (MBOT) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto al crecimiento, los márgenes y los gastos para calcular el valor intrínseco de Microbot Medical Inc. (MBOT) y dar forma a sus decisiones de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -7.2 -9.0 -11.3 -13.2 -10.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .1 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -7.2 -9.1 -11.4 -13.3 -10.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 31.3 24.6 15.5 8.2 6.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .3 .2 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories -2.6 .0 -.2 -.1 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .3 .3 .3 .1 .4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.2 -.1 -.1 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -7.3 -9.2 -11.3 105.7 -10.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -4.7 -12.1 -11.0 105.7 -10.5 -.4 .0 .0 .0 .0
WACC, % 11.98 11.98 11.98 11.89 11.98 11.96 11.96 11.96 11.96 11.96
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -2
Equity Value 2
Diluted Shares Outstanding, MM 10
Equity Value Per Share 0.19

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios.
  • Real-World Data: Microbot Medical Inc. (MBOT) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for testing projections, validating strategies, and saving time.

Key Features

  • Comprehensive Data Access: Microbot Medical Inc.’s (MBOT) detailed historical financials and projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: Watch Microbot Medical Inc.’s (MBOT) intrinsic value update instantly.
  • Intuitive Visualizations: Interactive dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Microbot Medical Inc.'s (MBOT) preloaded data.
  • 2. Adjust Key Inputs: Modify essential parameters such as growth rates, WACC, and capital expenditures.
  • 3. Instant Results: The DCF model automatically computes intrinsic value and NPV in real-time.
  • 4. Explore Different Scenarios: Evaluate various forecasts to assess multiple valuation possibilities.
  • 5. Present with Assurance: Deliver expert valuation insights to back your strategic decisions.

Why Choose This Calculator for Microbot Medical Inc. (MBOT)?

  • Precision: Utilizes real Microbot Medical financials for utmost data reliability.
  • Adaptability: Built to allow users to experiment and adjust inputs with ease.
  • Efficiency: Eliminate the need to construct a DCF model from the ground up.
  • Expert-Level: Crafted with the accuracy and functionality expected by CFOs.
  • Intuitive: Simple to navigate, even for those lacking advanced financial modeling skills.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for portfolio assessment related to Microbot Medical Inc. (MBOT).
  • Medical Device Companies: Evaluate valuation scenarios to inform strategic decisions within the industry.
  • Consultants and Advisors: Offer clients precise valuation insights for Microbot Medical Inc. (MBOT) stock.
  • Students and Educators: Leverage real-world data to practice and teach financial modeling in the healthcare sector.
  • Tech and Medical Enthusiasts: Gain insights into how innovative companies like Microbot Medical Inc. (MBOT) are valued in the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
  • Real-World Data: Microbot Medical Inc.'s (MBOT) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Visualizations and tables for clear, actionable insights.

No products were found matching.